These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
96 related articles for article (PubMed ID: 25865226)
1. Silencing of R-Spondin1 increases radiosensitivity of glioma cells. Gu X; Wang X; Xiao H; Ma G; Cui L; Li Y; Zhou H; Liang W; Zhao B; Li K Oncotarget; 2015; 6(12):9756-65. PubMed ID: 25865226 [TBL] [Abstract][Full Text] [Related]
2. Silencing erythropoietin receptor on glioma cells reinforces efficacy of temozolomide and X-rays through senescence and mitotic catastrophe. Pérès EA; Gérault AN; Valable S; Roussel S; Toutain J; Divoux D; Guillamo JS; Sanson M; Bernaudin M; Petit E Oncotarget; 2015 Feb; 6(4):2101-19. PubMed ID: 25544764 [TBL] [Abstract][Full Text] [Related]
3. Inhibition of MMP14 potentiates the therapeutic effect of temozolomide and radiation in gliomas. Ulasov I; Thaci B; Sarvaiya P; Yi R; Guo D; Auffinger B; Pytel P; Zhang L; Kim CK; Borovjagin A; Dey M; Han Y; Baryshnikov AY; Lesniak MS Cancer Med; 2013 Aug; 2(4):457-67. PubMed ID: 24156018 [TBL] [Abstract][Full Text] [Related]
4. Combination of intracranial temozolomide with intracranial carmustine improves survival when compared with either treatment alone in a rodent glioma model. Recinos VR; Tyler BM; Bekelis K; Sunshine SB; Vellimana A; Li KW; Brem H Neurosurgery; 2010 Mar; 66(3):530-7; discussion 537. PubMed ID: 20173548 [TBL] [Abstract][Full Text] [Related]
7. P2X7 receptor as predictor gene for glioma radiosensitivity and median survival. Gehring MP; Kipper F; Nicoletti NF; Sperotto ND; Zanin R; Tamajusuku AS; Flores DG; Meurer L; Roesler R; Filho AB; Lenz G; Campos MM; Morrone FB Int J Biochem Cell Biol; 2015 Nov; 68():92-100. PubMed ID: 26358881 [TBL] [Abstract][Full Text] [Related]
8. Pseudoprogression after radiotherapy with concurrent temozolomide for high-grade glioma: clinical observations and working recommendations. Chaskis C; Neyns B; Michotte A; De Ridder M; Everaert H Surg Neurol; 2009 Oct; 72(4):423-8. PubMed ID: 19150114 [TBL] [Abstract][Full Text] [Related]
9. Clinical features, management and outcomes of high-grade glioma patients in Ramathibodi Hospital. Chansriwong P; Sirisinha T J Med Assoc Thai; 2010 Feb; 93 Suppl 2():S68-73. PubMed ID: 21299082 [TBL] [Abstract][Full Text] [Related]
10. Prospective evaluation of radiotherapy with concurrent and adjuvant temozolomide in children with newly diagnosed diffuse intrinsic pontine glioma. Jalali R; Raut N; Arora B; Gupta T; Dutta D; Munshi A; Sarin R; Kurkure P Int J Radiat Oncol Biol Phys; 2010 May; 77(1):113-8. PubMed ID: 19647954 [TBL] [Abstract][Full Text] [Related]
11. Can hsp90alpha-targeted siRNA combined with TMZ be a future therapy for glioma? Cruickshanks N; Shervington L; Patel R; Munje C; Thakkar D; Shervington A Cancer Invest; 2010 Jul; 28(6):608-14. PubMed ID: 20210521 [TBL] [Abstract][Full Text] [Related]
12. Survival outcome and neurotoxicity in patients of high-grade gliomas treated with conformal radiation and temozolamide. Anand AK; Chaudhory AR; Aggarwal HN; Sachdeva PK; Negi PS; Sinha SN; Babu AG; Jena A; Rao A; Chaudhury PS J Cancer Res Ther; 2012; 8(1):50-6. PubMed ID: 22531514 [TBL] [Abstract][Full Text] [Related]
13. Erythropoietin augments survival of glioma cells after radiation and temozolomide. Hassouna I; Sperling S; Kim E; Schulz-Schaeffer W; Rave-Fränk M; Hasselblatt M; Jelkmann W; Giese A; Ehrenreich H Int J Radiat Oncol Biol Phys; 2008 Nov; 72(3):927-34. PubMed ID: 19014782 [TBL] [Abstract][Full Text] [Related]
14. Update in the treatment of high-grade Gliomas. Lukas RV; Nicholas MK Neurol Clin; 2013 Aug; 31(3):847-67. PubMed ID: 23896509 [TBL] [Abstract][Full Text] [Related]
15. [Pattern of care of high-grade gliomas]. Laigle-Donadey F; Sanson M Rev Prat; 2006 Oct; 56(16):1779-86. PubMed ID: 17315503 [TBL] [Abstract][Full Text] [Related]
16. A radiosensitivity gene signature and PD-L1 predict the clinical outcomes of patients with lower grade glioma in TCGA. Jang BS; Kim IA Radiother Oncol; 2018 Aug; 128(2):245-253. PubMed ID: 29784449 [TBL] [Abstract][Full Text] [Related]
18. Silencing of HIF-1α enhances the radiation sensitivity of human glioma growth in vitro and in vivo. Luo Z; Bai M; Xiao X; Zhang W; Liu X; Yang X; Li S; Huan Y; Wu Z; Zhang X; Cao W Neuropharmacology; 2015 Feb; 89():168-74. PubMed ID: 24859610 [TBL] [Abstract][Full Text] [Related]
19. Treatment of poorly differentiated glioma using a combination of monoclonal antibodies to extracellular connexin-43 fragment, temozolomide, and radiotherapy. Yusubalieva GM; Baklaushev VP; Gurina OI; Zorkina YA; Gubskii IL; Kobyakov GL; Golanov AV; Goryainov SA; Gorlachev GE; Konovalov AN; Potapov AA; Chekhonin VP Bull Exp Biol Med; 2014 Aug; 157(4):510-5. PubMed ID: 25110095 [TBL] [Abstract][Full Text] [Related]
20. [Recent advances in the medical treatment of glioma-temozolomide]. Nishikawa R No To Shinkei; 2006 Dec; 58(12):1035-41. PubMed ID: 17193953 [No Abstract] [Full Text] [Related] [Next] [New Search]